Skip to main content
Fig. 1 | Diabetology & Metabolic Syndrome

Fig. 1

From: Serum levels of 1,5-anhydroglucitol and 1,5-anhydrofructose-derived advanced glycation end products in patients undergoing hemodialysis

Fig. 1

Serum level of 1,5-AG. The serum 1,5-AG level in dialysis patients was measured on the dialysis day at the beginning of the week. In five patients (HD: 3, on-line HDF: 2), the 1,5-AG level was lower than the level allowing for measurement sensitivity, so these patients were excluded. The mean serum concentration of 1,5-AG was 21.3 ± 6.99 μg/mL in the control group. This level was significantly lowered to 1.93 ± 0.823 μg/mL and 2.23 ± 0.817 μg/mL in the HD and HDF groups, respectively. 1,5-AG, 1,5-anhydroglucitol; HD, hemodialysis; HDF, hemodiafiltration

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us